Quick Answer
CITIUS ONCOLOGY, INC. reported Research And Development Expense of $6.42 million for the year ending 2025.
- CITIUS ONCOLOGY, INC. showed an increase of +30.3% in Research And Development Expense from 2024 to 2025.
- This data is from CITIUS ONCOLOGY, INC.'s annual report (Form 10-K), filed with the SEC on December 23, 2025.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), CITIUS ONCOLOGY, INC.'s Research And Development Expense has grown by 51.4%.
- Historical annual values: Fiscal year 2025: $6.42 million | Fiscal year 2024: $4.93 million | Fiscal year 2023: $4.24 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: